Pfizer Celebrex Suit Stayed Pending High Court Case
A judge has stayed a securities fraud class action accusing Pfizer Inc. of misrepresenting clinical studies of arthritis painkiller Celebrex because the U.S. Supreme Court has decided to take on a...To view the full article, register now.
Already a subscriber? Click here to view full article